link管理
链接快照平台
- 输入网页链接，自动生成快照
- 标签化管理网页链接
相关文章推荐
|
精明的蚂蚁 · 游艇出海10项安全提示· 3 月前 · |
|
|
冲动的香槟 · 广东出台文件加快构建全过程创新链 ...· 5 月前 · |
|
|
想发财的菠萝 · Android ...· 7 月前 · |
|
|
独立的胡萝卜 · OpenWrt ...· 8 月前 · |
|
|
老实的电池 · 回顾阿沛-阿旺晋美百年人生：反对藏独脱颖而出 ...· 9 月前 · |
GetToolImpactFactorCommentsPageRequest(projectId=1, impactFactorId=7532, id=56a17532, selectType=1, sortType=1, contributeIds=null, level=null, parentIds=[])
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
[GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向：肿瘤分子生物学<br>经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学<br>经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制<br>经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享：投稿四天后改格式重新投，然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向：肿瘤<br>经验分享：四年的心血，前期投了一些杂志，有秒拒的，有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志，审稿很快，编辑和审稿人都很nice。4月21投，很快就审稿了，5月9号给大修，认真补了实验做了回复，6月18大修返回，6月24审稿人审完，6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问，杂志现在需要提供全膜的wb嘛，谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]
推荐文章
|
|
精明的蚂蚁 · 游艇出海10项安全提示 3 月前 |